# US 2013/0157895 A1 · Tissue staining method, tissue evaluation method and biosubstance detection method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157895 A1
- Document ID: US20130157895A1
- Status: Published application
- Kind: A1
- Application number: 13/819,574
- Filed: 2011-03-15
- Published: 2013-06-20
- Earliest claimed: 2010-08-30
- Assignees: Tohoku University; Konica Minolta Medical & Graphic, Inc.
- Inventors: Takuji Aimiya; Hideki Gouda; Hisatake Okada; Yasushi Nakano; Kohsuke Gonda; Motohiro Takeda; Noriaki Ohuchi
- Web page: https://patentgrep.com/patent/US20130157895A1

## CPC

- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/582: {with fluorescent label}
- G01N 33/588: {with semiconductor nanocrystal label, e.g. quantum dots}
- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- G01N 33/743: {Steroid hormones}
- G01N 2001/302: {Stain compositions}
- G01N 2021/6441: {with two or more labels}
- G01N 2333/71: for growth factors; for growth regulators
- G01N 2333/723: Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
- G01N 2333/91205: Phosphotransferases in general
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

A tissue staining method which comprises: staining a tissue with a staining reagent wherein a biosubstance recognition site is bonded to particles carrying multiple fluorescent substances accumulated therein; in the stained tissue, counting fluorescent points or measuring fluorescent brightness; and evaluating the expression level of a biosubstance, which matches the biosubstance recognition site, in the aforesaid tissue on the basis of the number of the fluorescent points or fluorescent brightness that was measured.

## Claims

### Claim 1

A tissue staining method comprising:
staining a tissue with a staining reagent comprising a particle holding plural phosphors, wherein a biosubstance-recognizing body is bound to the particle.

### Claim 2 (depends on 1)

The tissue staining method according to claim 1, wherein.
the particle holding plural phosphors contains the plural phosphors therein.

### Claim 3 (depends on 1)

The tissue staining method according to claim 1, wherein
the phosphor is a fluorescent dye, a semiconductor particle, or a rare-earth element particle.

### Claim 4 (depends on 1)

The tissue staining method according claim 1, wherein
the particle holding the plural phosphors has a particle diameter of 40 to 500 nm.

### Claim 5

A tissue evaluation method, comprising:
staining a tissue section with a staining reagent comprising a phosphor-holding particle which holds plural phosphors, wherein a biosubstance-recognizing body is hound to the phosphor-holding particle;
counting the number of bright spots of fluorescence in the stained tissue section; and
evaluating an expression level of a biosubstance corresponding to the biosubstance-recognizing body in the stained tissue section on the basis of the number of the counted bright spots.

### Claim 6 (depends on 5)

The tissue evaluation method according to claim 5, comprising:
measuring brightness of each bright spot in the stained tissue section;
determining a brightness distribution on the basis of the number of the counted bright spots and the be of each bright spot;
calculating the brightness per phosphor-holding particle on the basis of the brightness distribution;
calculating the number of the phosphor-holding particles bound to the stained tissue section on the basis of the sum of the measured brightnesses of the bright spots and the calculated brightness per phosphor-holding particle; and
evaluating the expression level of the biosubstance in the stained tissue section on the basis of the calculated number of the phosphor-holding particles.

### Claim 7

A biosubstance detection method for specifically detecting a biosubstance in a pathological section, the method comprising:
staining the pathological section with a staining reagent; and
detecting the biosubstance in the stained pathological section, wherein
in the staining of the pathological section, a first particle holding plural first phosphors where a first biosubstance-recognizing body is bound to the first particle and second particle holding plural second phosphors having a different fluorescence wavelength from a fluorescence wavelength of the first phosphor where a second biosubstance-recognizing body different from the first biosubstance-recognizing body is bound to the second particle are used as the staining reagent.

### Claim 8 (depends on 7)

The biosubstance detection method according to claim 7, wherein
the first biosubstance-recognizing body is an anti-human ER antibody; and
the second biosubstance-recognizing body is an anti-HER2 antibody.

### Claim 9 (depends on 7)

The biosubstance detection method according to claim 7, wherein
the first phosphor and the second phosphor are selected from organic fluorescent dyes and quantum dots.

### Claim 10 (depends on 7)

The biosubstance detection method according to claim 7, wherein
in the detecting of the biosubstance, an expression level of the biosubstance is determined by counting the number of bright spots.

### Claim 11 (depends on 7)

The biosubstance detection method according to claim 7, wherein
in the detecting of the biosubstance, an expression level of the biosubstance is determined by measuring luminescent brightness.
